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ORIGINAL ARTICLE
Objectives. To study the effect of maternal HIV status on perinatal outcome at Mowbray Maternity Hospital (a secondary-level hospital 
in Cape Town) and its satellite community midwife obstetric units.
Design. A retrospective descriptive and comparative study.
Setting. Public sector maternity facilities serving historically disadvantaged populations.
Subjects. All deliveries at Mowbray Maternity Hospital and its referral midwife obstetric units from January to December 2008.
Outcome measures. Stillbirth, early neonatal death, perinatal mortality and neonatal encephalopathy rates in HIV-positive and HIV-
negative subjects. 
Results. There was a total of 18 870 deliveries at the units studied, 3 259 (17.2%) of them to HIV-positive mothers. The stillbirth rate 
in the HIV-positive population was 17.1/1 000 births, compared with 8.3/1 000 in the HIV-negative population (odds ratio (OR), 2.07, 
95% confidence interval (CI) 1.5 - 2.8). The early neonatal death rate in the HIV-positive population was 4.6/1 000 live births, compared 
with 3.1/1 000 in the HIV-negative population (OR 1.46, 95% CI 0.8 - 2.6). The perinatal mortality rate in the HIV-positive population 
was 21.7/1 000 births, compared with 11.7 in the HIV-negative population (OR 1.91, 95% CI 1.4 - 2.5). A comparison of the pattern 
of primary obstetric causes of perinatal mortality showed that infection, intra-uterine growth restriction (IUGR) and antepartum 
haemorrhage (APH) were significantly more common as causes for perinatal death in the HIV-positive population. The risk of neonatal 
encephalopathy in the HIV-exposed population was 4.9/1 000 live births compared with 2.07 in the HIV-negative group (OR 2.36, 95% 
CI 1.28 - 4.35). The 1 643 women (8.7% of total deliveries) who were not tested for HIV were at particularly high risk of adverse perinatal 
outcome. This group included women who had either declined testing or not attended for antenatal care.
Conclusion. The perinatal mortality rate in the group of HIV-exposed mothers was significantly higher than that in the HIV-negative 
group due to a higher stillbirth rate. Infection, IUGR and APH were significantly more common obstetric causes for mortality in the 
HIV-infected population. The risk of neonatal encephalopathy was also significantly higher in the HIV-positive population.  
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By the end of 2009 there were 33.4 million people living with the 
human immunodeficiency virus (HIV), with sub-Saharan Africa 
being the regions worst affected.1 Anonymous seroprevalence 
studies of antenatal clinic attendees in South Africa reports an 
average national infection rate of 29 - 30% in this group.2  
Maternal HIV infection is a leading underlying cause of maternal 
and child morbidity and mortality in South Africa.3,4 In the Metro 
West (former Peninsula Maternal and Neonatal Service) of Cape 
Town, maternal HIV infection is known to have contributed to a 
recent increase in maternal mortality rates.5  
A review of the world literature suggests a clear association between 
HIV infection and stillbirth. A meta-analysis of 31 trials reported 
a fourfold increase in stillbirths if a group of mothers infected with 
HIV is compared with a similar group of mothers testing negative 
for HIV.6
In spite of a steady decline in perinatal mortality in First-World 
countries, it is feared that the HIV epidemic will negate any progress 
made in this regard in developing countries. This point is illustrated 
by a registry-based study done in Tanzania analysing 14  444 
singleton deliveries. The association between maternal HIV status 
and pregnancy outcome was studied, and the HIV-infected mothers 
were found to have a 75% higher risk of preterm delivery compared 
with the HIV-negative mothers. The risk of perinatal death in the 
HIV-infected group was found to be 89% higher than that in the 
non-infected group.7 
A smaller prospective study performed in Kenya, comparing 
perinatal outcome in a seropositive group of mothers with that 
in a matched seronegative group, found a significant increase 
in preterm birth in the seropositive group (21% v. 9.1%). In 
addition, a small increase in perinatal mortality was found in the 
seropositive group.8 
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In India, Kumar et al., studying the impact of HIV-1 on pregnancy 
outcome in a cohort of tribal women in Manipur district, 
confirmed a significantly higher incidence of placental membrane 
inflammation (histological evidence of funisitis or chorio-
amnionitis) in the HIV-positive group.9 They concluded that HIV 
infection was associated with adverse fetal outcome.
In Tshwane, South Africa, an audit in 2006 showed that both 
stillbirth and neonatal mortality rates were significantly higher 
for HIV-positive than HIV-negative mothers, with intrapartum 
asphyxia, preterm labour and infections contributing to the 
difference.10  
The association between HIV status and perinatal mortality at 
Mowbray Maternity Hospital (MMH) and in its referring midwife 
obstetric units (MOUs) is the subject of this study. At MMH 
during 2006 the perinatal mortality rate was recorded as 29.4/1 000 
deliveries. At the MOUs the perinatal mortality rate was 15.8/1 000 
deliveries. Annual routine statistics show that the prevalence of HIV 
infection among women delivering at MMH during 2006 was 19%.
Aims and objectives
The aim of this study was to study the impact of maternal HIV 
status on perinatal outcome at MMH, a secondary-level hospital in 
Cape Town, South Africa, and its catchment MOUs.
Specific objectives were: (i) to compare the perinatal mortality 
rate in HIV-exposed group with that in the HIV-negative group; 
(ii) to determine, where possible, the primary obstetric cause of 
adverse outcome and compare this in HIV-exposed and HIV-
negative women; and (iii) to compare the incidence of neonatal 
encephalopathy in the HIV-exposed group and the HIV-negative 
group. 
Methods
The study was a retrospective descriptive and comparative audit 
conducted during 2008. MMH is a level two obstetric hospital 
serving a low- to middle-income urban population. Three 
community MOUs refer to MMH: Khayelitsha, Guguletu and 
Mitchells Plain.
During the year of the study MMH and referral MOUs followed the 
Western Cape Department of Health prevention of mother-to-child 
transmission (PMTCT) policy. This included voluntary counselling 
and testing of all pregnant women for HIV. For seropositive women, 
CD4 estimation was performed and those with levels <250 cells/µl 
were referred for triple antiretroviral therapy. For HIV-positive 
women with CD4 counts above 250 cells/µl, routine PMTCT 
measures included treatment of the mother with zidovudine from 
28 weeks’ gestation as well as nevirapine as a single dose during 
labour. The newborn was treated with single-dose nevirapine 
and zidovudine for 1 or 4 weeks; infant feeding options included 
exclusive formula feeding or exclusive breastfeeding. 
All data pertaining to HIV testing, results and treatment were 
entered into the PMTCT registers for the facility. All deliveries at 
MMH and its referral MOUs from January 2008 to December 2008 
could therefore be audited with respect to HIV status.
All deliveries in which the outcome was a perinatal death (stillbirth 
or early neonatal death of an infant weighing 500 g or more) or a 
newborn infant with neonatal encephalopathy were identified, 
analysed in detail and discussed at the perinatal audit meetings held 
on a monthly basis at MMH and its satellite MOUs. For each adverse 
outcome a purpose-designed form is completed which includes 
demographic data, pregnancy and labour details, and the cause of 
adverse perinatal outcome. Cause of death is determined by clinical 
features as well as histological examination of the placenta. 
The forms, completed prospectively at the monthly meetings, were 
used to derive data for this study. In addition, data were entered into 
the South Africa Perinatal Problem Identification Program (PPIP) 
electronic database, and this was used to check for completeness of 
the data set. Cross-checking with registers was done, and for any 
missing data the folders were retrieved and missing data extracted.
Although not part of the PPIP, MMH has routinely collected data 
on infants with neonatal encephalopathy and discussed such cases 
at the monthly perinatal audit meetings since 2002. The diagnosis 
of neonatal encephalopathy was made by the neonatologists based 
on the Fenichel and Sarnat criteria and divided into mild, moderate 
and severe according to the Thompson (Groote Schuur) scoring 
system.11-13 
Approval for the study was granted by the UCT Faculty of Health 
Sciences Human Research Ethics Committee (HREC REF: 
282/2010). Since this was a register and folder review, no consent 
was required and confidentiality of data was ensured.
Results
There was a total of 18  870 deliveries at the units studied, 3 259 
(17.2%) of them to HIV-positive mothers (Table I).
At the time of the study CD4 testing was not universal, being 
done in 67% of the HIV-positive population. Of those with known 
CD4 counts, 48.3% had a count less than 350 cells/µl. The data on 





deliveries Total untested deliveries Total No. of deliveries
MMH 1 747 (18.7%) 7 044 (75.4%) 547 (5.8%) 9 338
Mitchells Plain MOU 368 (8.7%) 3 235 (77.1%) 589 (14%) 4 192
Khayelitsha MOU 659 (25.8%) 1 678 (65.7%) 216 (8.4%) 2 553
Guguletu MOU 485 (17.4%) 2 011 (72.1%) 291 (10.4%) 2 787
   Total 3 259 (17.2%) 13 968 (74%)  643 (8.7%) 18 870
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perinatal outcome in the HIV-positive group were not stratified by 
CD4 count. 
Table II shows the stillbirth, early neonatal death and perinatal 
mortality rates in HIV-positive and negative women for the 
combined population of MMH and the three MOUs.
There were 300 stillbirths in 2008, 56 in HIV-positive, 117 in 
HIV-negative and 127 in HIV-untested women. The stillbirth rate 
(number of stillbirths per 1 000 total births) in the HIV-positive 
population for the units studied was 17.1/1 000 births. In the HIV-
negative population the rate was 8.3/1 000 births. The odds ratio 
(OR) was 2.07 (95% confidence interval (CI) 1.5 - 2.8), with a 
p-value of <0.0001. 
There were 79 early neonatal deaths in 2008, 15 in HIV-positive, 44 
in HIV-negative and 20 in HIV-untested women. The early neonatal 
death rate in the HIV-positive population was 4.6/1 000 live births, 
compared with a rate of 3.1/1 000 in the HIV-negative population. 
The OR was 1.46 (95% CI 0.8 - 2.6), with a p-value of 0.26. 
The perinatal mortality rate in the HIV-positive population was 
21.7/1 000 births and that in the HIV-negative population 11.7/ 
1 000 births. The OR was 1.91 (95% CI 1.4 - 2.5), with a p-value of 
<0.0001.
A comparison of the pattern of primary obstetric causes of perinatal 
mortality showed that infection, intra-uterine growth restriction 
(IUGR) and antepartum haemorrhage (APH) were significantly 
more common causes of perinatal death in the HIV-positive 
population (Table III). In 75.3% of cases the findings of histological 
examination of the placenta were available and aided in the 
diagnosis of the primary cause of mortality; the rest of the diagnoses 
were made on clinical grounds. 
For perinatal deaths caused by infection, chorio-amnionitis was the 
pathological diagnosis. This diagnosis was made either clinically or 
by histological examination of the placenta for both HIV-positive 
and HIV-negative patients. Additional serological tests for infection, 
such as the TORCH screen, were rarely done, so these less common 
causes of perinatal infection were not identified.
In 2008, there were 54 babies diagnosed with neonatal 
encephalopathy (predominantly hypoxic ischaemic encephalo-
pathy), 16 in HIV-positive, 31 in HIV-negative and 7 in HIV-
untested women. The rate of neonatal encephalopathy in the HIV-
exposed population was 4.9/1 000 deliveries, compared with 2.07/1 
000 deliveries in the HIV-negative group. This statistic included all 
babies born with neonatal encephalopathy, some of whom had early 
neonatal deaths. Comparing the two groups, the OR was 2.36 (95% 
CI 1.28 - 4.35), with the p-value 0.008. 
This study showed the untested group of patients to be at a 
particularly high risk of adverse perinatal outcome. This group 
included both mothers who declined HIV testing and those who 
had no antenatal care in the index pregnancy.
There was no significant difference in age and parity between 
the HIV-positive and negative groups with regard to stillbirths or 
neonatal deaths (Tables IV and V). 
Table IV compares the results and statistical analysis of demographic 
data in the group of mothers with a stillbirth. The p-value was 
calculated comparing the HIV-exposed with the HIV-negative 
group.
Table V compares demographic data in HIV-positive and negative 
women with early neonatal deaths.
Table II. Comparison of perinatal mortality rates according to HIV status for the combined study population
HIV-positive HIV-negative Untested OR* (CI) p-value
Stillbirth rate 17.1/1 000 8.3/1 000 77.2/1 000 2.07 (1.5 - 2.8) <0.0001
Neonatal death rate 4.6/1 000 3.1/1 000 10.3/1 000 1.4 (0.81 - 2.6) 0.26
Perinatal mortality rate 21.7/1 000 11.5/1 000 87.6/1 000 1.91 (1.4 - 2.5) <0.0001
*Comparing HIV-positive with HIV-negative group.
Table III. Comparison of perinatal mortality rate per primary obstetric cause 
Primary obstetric cause HIV-positive HIV-negative Untested OR* (CI) p-value
Preterm labour 4.2/1 000 3.0/1 000 34.0/1 000 1.3 (0.76 - 2.5) 0.35
Infection 5.2/1 000 1.2/1 000 5.4/1 000 4.3 (2.19 - 8.4) <0.0001
Asphyxia 3.3/1 000 1.8/1 000 4.8/1 000 1.8 (0.89 - 3.6) 0.14
IUGR 3.0/1 000 0.6/1 000 2.4/1 000 4.7 (1.93 - 11.7) 0.0005
APH 3.6/1 000 1.2/1 000 12.1/1 000 2.8 (1.37 - 5.93) 0.006
Unexplained 2.7/1 000 1.8/1 000 13.9/1 000 1.48 (0.69 - 3.17) 0.41
Hypertension 0.3/1 000 0.5/1 000 4.8/1 000 0.5 (0.06 - 4.2) 0.86
Congenital abnormality 0.6/1 000 0.5/1 000 3.6/1 000 1.2 (0.2 - 5.9) 0.86
Other 0.0 0.4/1 000 4.2/1 000
*Comparing HIV-positive with HIV-negative group. 
Bold type indicates primary causes with statistically significant difference between the two study groups. 
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Discussion
The study findings that stillbirth and perinatal mortality rates were 
significantly higher in HIV-positive mothers compared with HIV-
negative mothers corresponds with other studies, including the 
Tshwane study.10 There was no significant difference in neonatal death 
rates; this could possibly be explained by the high quality of neonatal 
care at MMH. Our study showed that infection, IUGR and APH were 
significantly more common as a cause of perinatal death in HIV-
positive than HIV-negative mothers. This differs from the Tshwane 
study,10 where preterm labour and asphyxia were more common. 
However the neonatal encephalopathy rate was significantly higher in 
the HIV-exposed group and it is therefore possible that intrapartum 
hypoxia resulted in morbidity rather than mortality. 
Other researchers have shown an association between maternal HIV 
status and preterm labour,7 IUGR14-16 and APH.17 The mechanism by 
which maternal HIV infection could cause these adverse outcomes 
and the differences between different geographical areas are not 
currently understood, and require more research. It is possible 
that subclinical chorio-amnionitis may be more common in HIV-
infected mothers and that this could explain the association with 
preterm labour and perinatal hypoxia.9,18 
Our data also indicate no significant differences in demographic 
factors and birth weight between HIV-exposed and negative groups, 
therefore excluding these as possible confounding factors for the 
study findings. This study did not collect information on socio-
economic status; this is known to independently influence perinatal 
outcome and could also be associated with a higher prevalence of 
HIV infection. The effect of low socio-economic status as a potential 
confounding factor for the observed association between maternal 
HIV infection and perinatal mortality needs to be further explored.
The current study also did not stratify HIV-positive mothers by CD4 
count or HIV clinical staging. This needs to be investigated by future 
 
 
research, as does the impact of antiretroviral treatment on perinatal 
outcome. 
Our study and others referred to in this paper were done in 
resource-limited countries but results in a study by Ellis et al. in 
a large inner city hospital in Atlanta, USA, were similar.19 They 
comment in their conclusion that a seropositive mother was ‘more 
likely to have a perinatal death’.19 
The increased risk of neonatal encephalopathy in the HIV-exposed 
group could be due to the immune suppression caused by the virus 
resulting in higher rates of clinical and subclinical intra-uterine 
infection. The fetus exposed to this environment has a much 
reduced capacity to tolerate the stress of labour without becoming 
acidotic and suffering the consequences thereof.20 Several studies 
have found chorio-amnionitis to be a risk factor for neonatal 
encephalopathy.21,22 
Our results indicate that the group of patients who did not have 
an HIV test during the pregnancy was at much higher risk of 
perinatal mortality and morbidity than the other two groups. The 
untested group consists mainly of patients who were ‘unbooked’ 
at any medical institution for antenatal care, and a small number 
who declined a test. Lack of antenatal care is thought to be an 
independent risk factor for adverse pregnancy outcome.  
Conclusion
Perinatal mortality and neonatal encephalopathy rates at MMH and 
referring MOUs were significantly higher in an HIV-exposed group 
compared with HIV-negative counterparts. Infection, IUGR and 
APH were more common as obstetric causes for mortality in the 
HIV-positive group.
More comprehensive testing is needed to reduce the number of 
HIV-untested mothers.
Table IV. Comparison of demographics by HIV status in the group of mothers with stillbirth 
HIV-positive HIV-negative Untested p-value*
Maternal age (yrs)(mean (SD)) 27.9 (5.9) 25.9 (5.4) 24.9 (6.1) 0.076 (NS)
Birth weight (g) (median) 1 400 2 010 1 040 0.678 (NS)
Gestation (wks) (median) 32 32 27.5 0.525 (NS)
Gravidity (median)  2 2 1
Parity (median)   1 1 0
*Comparing HIV-positive and HIV-negative groups.
SD = standard deviation; NS = non-significant.
Table V. Comparison of demographic data by HIV status in group of mothers with early neonatal death 
HIV-positive HIV-negative Untested p-value* 
Maternal age (yrs) (mean (SD)) 27.2 (2.8) 26.2 (5.9) 25.2 (6.7) 0.362 (NS)
Birth weight (g) (median) 900  1 020 920 0.208 (NS)
Gravidity (median)  2  2  3
Parity (median)  1  1  3
*Comparing HIV-positive and HIV-negative groups.
NS = non-significant. 
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